Pharma Journalist - Page 110 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy

City of Hope scientists develop new potential treatment for brain tumors

European Commission Grants Expanded Marketing Authorization for Gilead’s Biktarvy for the Treatment of HIV in Pediatric Populations

ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP

C4XD signs exclusive global licence worth up to $402 million with AstraZeneca for the development and commercialisation of NRF2 Activator programme

Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline

Exploring the Implementation of Complex In-vitro Models for Drug Development

Biocytogen Enters into Antibody Agreement with ADC Therapeutics

GARDP and Mitsubishi Tanabe Pharma Corporation announce partnership in search for new antibiotics

AbbVie Announces European Commission Approval of SKYRIZI (risankizumab) for the Treatment of Moderate to Severe Active Crohn’s Disease